Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous vs Non-Myeloablative Allogeneic HSCT for Follicular Lymphoma
NCT00096460Phase 3Terminated
- Sponsor
- Medical College of Wisconsin
- Start
- Aug 2004
- Primary completion
- Mar 2006
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 3, open-label trial of hematopoietic stem cells in follicular lymphoma (FL) (2 arms), sponsored by Medical College of Wisconsin. Primary endpoint: Lymphoma Progression-free Survival at 3 years. Started Aug 2004; status: terminated.
02
Drugs
hematopoietic stem cells
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00096460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00096460.